The title is the key message of Mark Frye, M.D,, head of Mayo Clinic's department of psychiatry and psychology today to a group of 20 top medical journalists in Rochester, MN. Just in this morning from the national psychiatry conference in Toronto, Dr. Frye told fellows from the National Press Club Foundation how precision medicine testing can alert physicians as to the appropriate medication for someone with bipolar disorder and also serve as a diagnostic tool. He also outline how Mayo's Bipolar Biobank is helping in research on new treatments for bipolar disorder.
He told the reporters that a person who has one bipolar manic episode has a 90 percent chance of having another, and a patient who has had two episodes has a 99 percent chance of having another. Bipolar disorder is also rated by the World Health Organization as the 15th leading cause of mortality among individuals aged 15 to 44.
The fellows include leading medical journalists from Time, CNN, the Los Angles Times, Chicago Tribune, Boston Globe, Reuters, Huffington Post, PBS and other major outlets. They are concluding a three day site visit focused on understanding precision or individualized medicine. They are being hosted by Mayo's Center for Individualized Medicine. They also heard from two directors from the National Institutes of Health: Dr. Roderic Pettigrew, National Institute of Biomedical Imaging and Bioengineering, and Dr. Gary Gibbons, National Heart, Lung and Blood Institute.